The activity of cytosolic phospholipase A2 is required for the lysis of adenovirus-infected cells by tumor necrosis factor

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8502-8507

  Thorne, Terry E ^a   Voelkel Johnson, Christina ^a   Casey, Warren M ^a   Parks, Leo W ^a   Laster, Scott M ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; PHOSPHOLIPASE A2; PHOSPHOLIPASE INHIBITOR; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; DIAGNOSIS; ENZYME BINDING; ENZYME MECHANISM; ENZYME REGULATION; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029861656     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8502-8507.1996     Document Type: Article

References (41)

1. Arany, Z., W. R. Sellers, D. M. Livingston, and R. Eckner. 1994. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77:799-800.
2. Bandara, L. R., and N. B. La Thangue. 1991. Adenovirus E1A prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature (London) 351:494-497.
3. Carswell, E. A., L. J. Old, R. L. Kassel, S. Green, N. Fiore, and B. Williamson. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72:3666-3670.
4. Chang, D. J., G. M. Ringold, and R. A. Heller. 1992. Cell killing and induction of manganous Superoxide dismutase by tumor necrosis factor-α is mediated by lipoxygenase metabolites of arachidonic acid. Biochem. Biophys. Res. Commun. 188:538-546.
5. Chen, M.-J., B. Holskin, J. Strickler, J. Gorniak, M. A. Clark, P. J. Johnson, M. Mitcho, and D. Shalloway. 1987. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF. Nature (London) 330:581-583.
6. 2+-dependent translocation domain with homology to PKC and GAP. Cell 65:1043-1051.
7. Dealtry, G., M. S. Naylor, W. Fiers, and F. R. Balkwill. 1987. DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by Interferon-γ. Eur. J. Immunol. 17:689-693.
8. Duerksen-Hughes, P., W. S. M. Wold, and L. R. Gooding. 1989. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143:4193-4200.
9. Duerksen-Hughes, P. J., T. W. Hermiston, W. S. M. Wold, and L. R. Gooding. 1991. The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells. J. Virol. 65:1236-1244.
10. Fransen, L., J. Van Der Heyden, R. Ruysschaert, and W. Fiers. 1986. Recombinant tumor necrosis factor: its effect and its synergism with interferon-γ on a variety of normal and transformed cell lines. Eur. J. Cancer Clin. Oncol. 22:419-426.
11. Ginsberg, H. S., U. Lundholm-Beauchamp, R. L. Horswood, B. Pernis, W. S. M. Wold, R. M. Chanock, and G. A. Prince. 1989. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86:3823-3827.
12. Gooding, L. R., L. W. Elmore, A. E. Tollefson, H. A. Brady, and W. S. M. Wold. 1988. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53:341-346.
13. Gooding, L. R., T. S. Ranheim, A. E. Tollefson, L. Aquino, P. Duerksen-Hughes, T. M. Horton, and W. S. M. Wold. 1991. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J. Virol. 65:4114-4123.
14. 2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 268:11290-11295.
15. Jayadev, S., C. M. Linardic, and Y. A. Hannun. 1994. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor α. J. Biol. Chem. 269:5757-5763.
16. Klimpel, G. R., R. Shaban, and D. W. Niesel. 1990. Bacteria-infected fibroblasts have enhanced susceptibility to the cytotoxic action of tumor necrosis factor. J. Immunol. 145:711-717.
17. Koff, W. C., and A. V. Fann. 1986. Human tumor necrosis factor-α kills herpes virus-infected cells but not normal cells. Lymphokine Res. 5:215-221.
18. Krajcsi, P., T. Dimitrov, T. W. Hermiston, A. E. Tollefson, T. S. Ranheim, S. B. Vande Pol, A. H. Stephenson, and W. S. M. Wold. 1996. The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. J. Virol. 70: 4904-4913.
19. Kull, F. C., and P. Cuatrecasas. 1981. Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum. Cancer Res. 41:4885-4890.
20. Lancaster, J. R., S. M. Laster, and L. R. Gooding. 1989. Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor. FEBS Lett. 248:169-174.
21. 2. Semin. Virol. 5:431-442.
22. Laster, S. M., J. G. Wood, and L. R. Gooding. 1988. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol. 141: 2629-2634.
23. 2 is phosphorylated and activated by MAP kinase. Cell 72:269-278.
24. 2. J. Biol. Chem. 271:6010-6016.
25. Lorence, R. M., P. A. Rood, and K. W. Kelley. 1988. Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-α and augmentation of its cytotoxicity. J. Natl. Cancer Inst. 80:1305-1312.
26. Manson, J., T. Brown, and G. Duff. 1990. Modulation of interleukin 1 beta gene expression using antisense phosphorothioate oligonucleotides. Lymphokine Res. 9:35-42.
27. Matsuyama, T., Y. Hamamoto, G.-I. Soma, D. Mizuno, N. Yamamoto, and N. Kobayashi. 1989. Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication. J. Virol. 63:2504-2509.
28. Ostrove, J. M., and G. E. Gifford. 1979. Stimulation of RNA synthesis in L929 cells by rabbit tumor necrosis factor. Proc. Soc. Exp. Biol. Med. 160: 354-358.
29. Reid, T., C. S. Ramesha, and G. M. Ringold. 1991. Resistance to killingby tumor necrosis factor in an adipocyte cell line caused by a defect in arachidonic acid biosynthesis. J. Biol. Chem. 266:16580-16586.
30. 2 activity is not involved in the tumor necrosis factor-triggered apoptotic DNA fragmentation in bovine aortic endothelial cells. Biochem. Biophys. Res. Commun. 188:1312-1317.
31. 2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis. J. Biol. Chem. 269:25999-26005.
32. 2. Biochim. Biophys. Acta 1044:139-146.
33. Shisler, J., P. Duerksen-Hughes, T. M. Hermiston, W. S. M. Wold, and L. R. Gooding. 1996. Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis. J. Virol. 70:68-77.
34. 2. Biochemistry 32:5935-5940.
35. Sugarman, B. J., B. B. Aggarwal, P. E. Hass, I. S. Figari, M. A. Palladino, Jr., and H. M. Shepard. 1985. Recombinant human tumor necrosis factor-a: effects on proliferation of normal and transformed cells in vitro. Science 230:943-945.
36. Tracey, K. J., and A. Cerami. 1993. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell. Biol. 9:317-343.
37. Voelkel-Johnson, C., A. J. Entingh, W. S. M. Wold, L. R. Gooding, and S. M. Laster. 1995. Activation of intracellular proteases is an early event in TNF-induced apoptosis. J. Immunol. 154:1707-1716.
38. 2 in human melanoma tumor cells. J. Immunol. 156:201-207.
39. White, E., P. Sabbatini, M. Debbas. W. S. M. Wold, D. I. Kusher, and L. R. Gooding. 1992. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α. Mol. Cell. Biol. 12:2570-2580.
40. Wold, W. S. M., S. L. Deutscher, N. Takemori, B. M. Bhat, and S. C. Magie. 1986. Evidence that AGUAUAUGA and CCAAGAUGA initiate translation in the same mRNA in region E3 of adenovirus. Virology 148:168-180.
41. Zhu, H., Y. Shen, and T. Shenk. 1995. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69:7960-7970.